BioCentury | Nov 3, 2014
Company News

Redwood Bioscience, Catalent deal

...using Redwood's SMARTag technology. Catalent declined to disclose financial details (see BioCentury, April 15, 2013). Redwood Bioscience Inc....
BioCentury | Aug 19, 2013
Product Development

The next wave in ADCs

...also has an ADC discovery and development deal with Celgene Corp. Like Ambrx and Sutro, Redwood Bioscience Inc....
...Inc. , Cambridge, Mass. Pfizer Inc. (NYSE:PFE), New York, N.Y. PolyTherics Ltd. , London, U.K. Redwood Bioscience Inc....
...payload to mAb NA (co provides drug discovery services and does no internal drug development) Redwood Bioscience Inc....
BioCentury | Apr 15, 2013
Company News

Catalent Pharma, Redwood Bioscience deal

...provide details, and Redwood could not be reached. Catalent Pharma Solutions Inc. , Somerset, N.J. Redwood Bioscience Inc....
BioCentury | Jul 9, 2012
Tools & Techniques

Taking ADCs beyond oncology

...Allozyne's programs are in discovery, and Sutro hasn't disclosed the development status of its programs. Redwood Bioscience Inc....
...NYSE:MRK), Whitehouse Station, N.J. Merck KGaA (Xetra:MRK), Darmstadt, Germany Pfizer Inc. (NYSE:PFE), New York, N.Y. Redwood Bioscience Inc....
BioCentury | Oct 10, 2011
Company News

Redwood Bioscience board of directors update

Redwood Bioscience Inc. , Burlingame, Calif. Business: Proteomics Appointed: Peter Van Vlasselaer as executive chairman, while remaining executive chairman of iPierian Inc. WIR Staff...
BioCentury | Aug 1, 2011
Emerging Company Profile

Redwood Bioscience: Tagging ADCs

...companies are developing methods that provide greater control over where the toxin payloads are attached. Redwood Bioscience Inc....
...Seattle, Wash. Genentech Inc. , South San Francisco, Calif. ImmunoGen Inc. (NASDAQ:IMGN), Waltham, Mass. Redwood Bioscience Inc....
...Biopharma Inc. , South San Francisco, Calif. University of California, Berkeley , Berkeley, Calif. Sidebars Redwood Bioscience Inc....
BioCentury | Jul 4, 2011
Financial News

Redwood Bioscience completes venture financing

Redwood Bioscience Inc. , Burlingame, Calif. Business: Proteomics Date completed: 6/27/11 Type: Venture financing Raised: Not disclosed Investor: Takeda Ventures WIR Staff...
BioCentury | May 3, 2010
Financial News

Redwood Bioscience completes venture financing

Redwood Bioscience Inc. , Burlingame, Calif. Business: Proteomics Date completed: 4/26/10 Type: Venture financing Raised: Undisclosed Investor: Mission Bay Capital WIR Staff...
BioCentury | Jan 29, 2009
Distillery Techniques

Technology: Chemistry

...SciBX 2(4); doi:10.1038/scibx.2009.161 Published online Jan. 29, 2009 Worldwide patent application filed; exclusively licensed to Redwood Bioscience Inc....
Items per page:
1 - 9 of 9
BioCentury | Nov 3, 2014
Company News

Redwood Bioscience, Catalent deal

...using Redwood's SMARTag technology. Catalent declined to disclose financial details (see BioCentury, April 15, 2013). Redwood Bioscience Inc....
BioCentury | Aug 19, 2013
Product Development

The next wave in ADCs

...also has an ADC discovery and development deal with Celgene Corp. Like Ambrx and Sutro, Redwood Bioscience Inc....
...Inc. , Cambridge, Mass. Pfizer Inc. (NYSE:PFE), New York, N.Y. PolyTherics Ltd. , London, U.K. Redwood Bioscience Inc....
...payload to mAb NA (co provides drug discovery services and does no internal drug development) Redwood Bioscience Inc....
BioCentury | Apr 15, 2013
Company News

Catalent Pharma, Redwood Bioscience deal

...provide details, and Redwood could not be reached. Catalent Pharma Solutions Inc. , Somerset, N.J. Redwood Bioscience Inc....
BioCentury | Jul 9, 2012
Tools & Techniques

Taking ADCs beyond oncology

...Allozyne's programs are in discovery, and Sutro hasn't disclosed the development status of its programs. Redwood Bioscience Inc....
...NYSE:MRK), Whitehouse Station, N.J. Merck KGaA (Xetra:MRK), Darmstadt, Germany Pfizer Inc. (NYSE:PFE), New York, N.Y. Redwood Bioscience Inc....
BioCentury | Oct 10, 2011
Company News

Redwood Bioscience board of directors update

Redwood Bioscience Inc. , Burlingame, Calif. Business: Proteomics Appointed: Peter Van Vlasselaer as executive chairman, while remaining executive chairman of iPierian Inc. WIR Staff...
BioCentury | Aug 1, 2011
Emerging Company Profile

Redwood Bioscience: Tagging ADCs

...companies are developing methods that provide greater control over where the toxin payloads are attached. Redwood Bioscience Inc....
...Seattle, Wash. Genentech Inc. , South San Francisco, Calif. ImmunoGen Inc. (NASDAQ:IMGN), Waltham, Mass. Redwood Bioscience Inc....
...Biopharma Inc. , South San Francisco, Calif. University of California, Berkeley , Berkeley, Calif. Sidebars Redwood Bioscience Inc....
BioCentury | Jul 4, 2011
Financial News

Redwood Bioscience completes venture financing

Redwood Bioscience Inc. , Burlingame, Calif. Business: Proteomics Date completed: 6/27/11 Type: Venture financing Raised: Not disclosed Investor: Takeda Ventures WIR Staff...
BioCentury | May 3, 2010
Financial News

Redwood Bioscience completes venture financing

Redwood Bioscience Inc. , Burlingame, Calif. Business: Proteomics Date completed: 4/26/10 Type: Venture financing Raised: Undisclosed Investor: Mission Bay Capital WIR Staff...
BioCentury | Jan 29, 2009
Distillery Techniques

Technology: Chemistry

...SciBX 2(4); doi:10.1038/scibx.2009.161 Published online Jan. 29, 2009 Worldwide patent application filed; exclusively licensed to Redwood Bioscience Inc....
Items per page:
1 - 9 of 9